SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+1.37%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$451M
AUM Growth
+$451M
(+39%)
Cap. Flow
+$52.2M
Cap. Flow
% of AUM
11.58%
Top 10 Holdings %
Top 10 Hldgs %
37.93%
Holding
109
New
31
Increased
24
Reduced
17
Closed
18
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$17M |
| 2 |
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
|
$16M |
| 3 |
AMN Healthcare
AMN
|
$15.9M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$14.8M |
| 5 |
Cigna
CI
|
$13.8M |
Top Sells
| 1 |
Merck
MRK
|
$8.84M |
| 2 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$8.51M |
| 3 |
CBAY
Cymabay Therapeutics
CBAY
|
$8.26M |
| 4 |
Eli Lilly
LLY
|
$7.54M |
| 5 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$7.25M |
Sector Composition
| 1 | Healthcare | 83.97% |
| 2 | Consumer Staples | 0.92% |
| 3 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYNH
26
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $5.92M | 1.17% |
+111,285
| New | +$5.92M |
|
27
Curis
CRIS
$21.5M
| $5.79M | 1.15% |
4,950,051
+650,000
| +15% | +$761K |
|
28
Kodiak Sciences
KOD
$453M
| $5.46M | 1.08% |
92,150
+71,555
| +347% | +$4.24M |
|
29
Mersana Therapeutics
MRSN
$34.8M
| $5.43M | 1.08% |
291,781
-80,000
| -22% | -$1.49M |
|
|
ARNA
30
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $5.37M | 1.06% |
71,753
-23,400
| -25% | -$1.75M |
|
|
CSII
31
DELISTED
Cardiovascular Systems, Inc.
CSII
| $4.91M | 0.97% |
+124,808
| New | +$4.91M |
|
32
Larimar Therapeutics
LRMR
$337M
| $4.56M | 0.9% |
300,591
-17,667
| -6% | -$268K |
|
33
ESSA Pharma
EPIX
$11.2M
| $4.53M | 0.9% |
+656,043
| New | +$4.53M |
|
34
Elevance Health
ELV
$72.4B
| $4.31M | 0.85% |
16,031
-15,788
| -50% | -$4.24M |
|
|
CHAQ.U
35
DELISTED
Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one
CHAQ.U
| $4.22M | 0.84% |
400,000
| – | – |
|
36
Quanterix
QTRX
$202M
| $4.2M | 0.83% |
124,609
-21,298
| -15% | -$719K |
|
37
Herbalife
HLF
$1.02B
| $4.13M | 0.82% |
+88,600
| New | +$4.13M |
|
38
Viking Therapeutics
VKTX
$3.02B
| $4.13M | 0.82% |
709,780
| – | – |
|
39
Medtronic
MDT
$118B
| $4.05M | 0.8% |
+39,000
| New | +$4.05M |
|
40
Ardelyx
ARDX
$1.57B
| $3.96M | 0.78% |
754,321
+152,787
| +25% | +$802K |
|
41
Becton Dickinson
BDX
$54.3B
| $3.86M | 0.76% |
+16,573
| New | +$3.86M |
|
42
RadNet
RDNT
$5.46B
| $3.43M | 0.68% |
223,561
+88,307
| +65% | +$1.36M |
|
43
Anika Therapeutics
ANIK
$130M
| $3.33M | 0.66% |
94,102
+58,070
| +161% | +$2.05M |
|
|
AFMD
44
DELISTED
Affimed
AFMD
| $3.09M | 0.61% |
911,279
-21,871
| -2% | -$74.1K |
|
45
Leap Therapeutics
LPTX
$12M
| $2.88M | 0.57% |
1,451,998
-50,000
| -3% | -$99K |
|
|
LSACU
46
DELISTED
LifeSci Acquisition Corp. Unit 1 COM & 1 WT
LSACU
| $2.86M | 0.57% |
210,000
| – | – |
|
47
Orchestra BioMed
OBIO
$147M
| $2.75M | 0.54% |
+250,000
| New | +$2.75M |
|
|
ASLN
48
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $2.62M | 0.52% |
1,376,954
| – | – |
|
49
Cross Country Healthcare
CCRN
$420M
| $2.6M | 0.52% |
+401,235
| New | +$2.6M |
|
50
Avalo Therapeutics
AVTX
$139M
| $2.35M | 0.46% |
1,030,776
+30,776
| +3% | +$72.1K |
|